1. World Health Organization
17 June, 2018
Countries using and
planning to introduce IPV
and the global status of
bOPV registration

2. World Health Organization
17 June 2018
Countries using and planning to introduce IPV 17 March 2016 status report
This slide deck provides a summary per country on the status of planning for the introduction of Inactivated Poliomyelitis Vaccine (IPV).
It also includes a summary of the global status of national registration of bivalent Oral Polio Vaccine (bOPV), in preparation for the switch from trivalent OPV (tOPV) to bOPV.
Information here is updated monthly based on information shared by WHO and UNICEF Regional Offices. Please contact with any questions or updates on this data.
Definition:
Formal decision to introduce: The country has documentation of its decision to introduce IPV which has been verified by the relevant WHO Regional Office, or for Gavi eligible countries, a complete application for IPV has been submitted to the Gavi Secretariat.
Tracking these decisions and informal intents provide an indication of the global trend towards meeting the targets of the Polio Eradication and Endgame Strategic Plan.

3. Countries using IPV vaccine to date and formal decision to introduce
World Health Organization
17 June, 2018
Introduced to date
Afghanistan Albania Algeria Andorra Antigua and Barbuda Australia Austria Azerbaijan Bahamas (the) Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Brazil Brunei Darussalam Bulgaria Burundi Cambodia Cameroon Canada Central African Republic (the) Chad Chile China Colombia Comoros (the) Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic (the) Denmark Dominica Dominican Republic (the) DPR Korea DR Congo Ecuador El Salvador Estonia Ethiopia Fiji Finland France Gabon Gambia (the) Georgia Germany Greece Grenada Guatemala Guinea Guyana Haiti Honduras Hungary Iceland India Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Lao People's Democratic Republic (the) Latvia Lebanon Libya Lithuania Luxembourg Madagascar Malaysia Maldives Malta Marshall Islands (the) Mauritania Mauritius Mexico Micronesia (Federated States of) Monaco Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands (the) New Zealand Nicaragua Niger (the) Nigeria Niue Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines (the) Poland Portugal Qatar Rep of Korea Romania Russian Federation (the) Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Saudi Arabia Senegal Serbia Seychelles Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Sudan Spain Sri Lanka Sudan (the) Suriname Sweden Switzerland Syrian Arab Republic (the) Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tonga Trinidad and Tobago Tunisia Turkey Tuvalu Ukraine United Arab Emirates (the) United Kingdom of Great Britain and Northern Ireland (the) United States of America (the) Uruguay Vanuatu Venezuela (Bolivarian Republic of) Yemen
Formal commitment to introduce in 2016
Angola Argentina Armenia Burkina Faso Cabo Verde Congo (the) Djibouti Egypt Equatorial Guinea Eritrea Ghana Guinea-Bissau Indonesia Kyrgyzstan Lesotho Liberia Malawi Mali Mongolia Republic of Moldova (the) Rwanda Sao Tome and Principe Sierra Leone Swaziland Tajikistan Togo Turkmenistan Uganda United Republic of Tanzania (the) Uzbekistan Viet Nam Zambia Zimbabwe
Introduction delayed to 2017
Eritrea Mongolia Tajikistan Togo United Republic of Tanzania (the) Uzbekistan Zimbabwe
Since January 2013, the following countries have introduced IPV: Kazakhstan, Peru & Singapore (July 2013); Micronesia (August 2013); Libya (April 2014); Albania & Panama (May 2014); Nepal & Tunisia (September 2014); Philippines (October 2014); China (December 2014); Comoros, Senegal & Serbia (January 2015); Colombia & Nigeria (February 2015); Bangladesh & Maldives (March 2015); DR Congo, DPR Korea & The Gambia (April 2015); Madagascar (May 2015); Cote d'Ivoire, Grenada, Kiribati, Morocco, St Vincent and the Grenadines & Sudan (June 2015); Bhutan, Cameroon, Niger, Pakistan, Philippines & Sri Lanka (July 2015); Benin, Chad, Papua New Guinea, The Former Yug. Rep. of Macedonia (August 2015); Afghanistan, CAR, Dominica, Guyana, Iran, Jamaica, Seychelles & Solomon Islands (September 2015); Bahamas, Lao People's Dem Rep, Nauru, Samoa (October 2015); Antigua and Barbuda, Botswana, Burundi, Cook Islands, Guinea, India, Mauritania, Mauritius, Mozambique, Namibia, Nicaragua, St Lucia, Suriname, Tuvalu, Vanuatu & Yemen (November 2015); Algeria, Belize, Cambodia, Dominical Rep, Ecuador, Ethiopia, Fiji, Gabon, Georgia, Honduras, Kenya, Myanmar, Paraguay, St Kitts & Nevis, S. Sudan, Thailand, Tonga & Trinidad & Tobago (December 2015); Cuba, El Salvador, Guatemala, Haiti, Iraq & Venezuela (Bolivian Rep of) (January 2016); Azerbaijan, Bolivia & Timor-Leste (February 2016); Chile (March 2016)
Introduced to date*
(161 countries or 83%)
Formal commitment to introduce in 2016
(26 countries or 13%)
Introduction delayed to 2017
(7 countries or 4%)
Not available
Not applicable
Data source: WHO/IVB Database, as of 17 March 2016
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
* Including partial introduction in Haiti, India & Venezuela
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 17 March 2016

4. World Health Organization
17 June, 2018
Overview of Global birth cohort by IPV status/tier (100% = 136.1million births in 2015)
IPV-using
Formal commitment to introduce in 2016 before tOPV/bOPV switch
Introduction delayed after April 2016
Data source: WHO/IVB Database, as of 17 March 2016 and United Nations, Department of Economic and Social Affairs, Population Division (2015). World Population Prospects: The 2015 Revision

5. bOPV registration status for routine immunization
World Health Organization
17 June, 2018
Approval for use
Afghanistan Albania Algeria Angola Antigua and Barbuda Argentina Armenia Azerbaijan Bahamas (the) Bahrain Bangladesh Barbados Belize Benin Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Botswana Burkina Faso Burundi Cabo Verde Cambodia Cameroon Central African Republic (the) Chad Chile China Colombia Comoros (the) Congo (the) Cook Islands Cote d'Ivoire Cuba Djibouti Dominica Dominican Republic (the) DPR Korea DR Congo Ecuador Egypt El Salvador Equatorial Guinea Eritrea Ethiopia Fiji Gabon Gambia (the) Georgia Ghana Grenada Guatemala Guinea Guinea-Bissau Guyana Haiti Honduras India Indonesia Iran (Islamic Republic of) Iraq Israel Jamaica Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic (the) Lebanon Lesotho Liberia Libya Madagascar Malawi Maldives Mali Mauritania Mauritius Mongolia Montenegro Morocco Mozambique Myanmar Namibia Nauru Nepal Nicaragua Niger (the) Nigeria Oman Pakistan Panama Papua New Guinea Paraguay Peru Philippines (the) Qatar Republic of Moldova (the) Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Solomon Islands Somalia South Africa South Sudan Sri Lanka Sudan (the) Suriname Swaziland Syrian Arab Republic (the) Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Uganda United Arab Emirates (the) United Republic of Tanzania (the) Uzbekistan Vanuatu
Venezuela (Bolivarian Republic of) Yemen Zambia Zimbabwe
Review in progress
Brazil, Mexico, Russian Federation (the), Ukraine
Pending submission
Viet Nam
Approval for use
(139 countries)
Review in progress
(Brazil, Mexico, Russian Fed., Ukraine)
(4 countries)
Pending submission (Viet Nam)
(1 country)
Data source: WHO/IVB Database, as of 17 March 2016
based on 148 OPV user countries and 7 Territories
Map production Immunization Vaccines and Biologicals (IVB),
World Health Organization
Not available/ non switch countries
(46 countries) + 4 countries switching from tOPV to IPV
Not applicable (switch area territories)
The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO All rights reserved.
Date of slide: 17 March 2016